DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

THYROCARE vs VIJAYA: Stock Comparison

THYROCARE TECH vs VIJAYA DIAGNOSTIC CENUpdated 13 Nov 26, 4:08 PM ISTNSE & company filings

VIJAYA DIAGNOSTIC CEN is the larger company by market capitalisation. THYROCARE TECH shows a lower P/E, a higher ROE and a higher dividend yield, while VIJAYA DIAGNOSTIC CEN shows faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

THYROCARE leads 6; VIJAYA leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

THYROCAREVIJAYA

Valuation lens

What price are you paying?

Market CapContext only
₹7,926 Cr
₹14,449 Cr
P/E RatioTHYROCARE has the lower reading
54.97x ✓
70.88x
P/B RatioVIJAYA has the lower reading
14.32x
13.65x ✓
EPSVIJAYA has the higher reading
₹1
₹5.77 ✓
Book ValueContext only
₹36.82
₹92.93
Dividend YieldTHYROCARE has the higher reading
1.41% ✓
0.14%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
VIJAYA is the larger company
₹14,449 Cr vs ₹7,926 Cr
P/E Ratio
THYROCARE has a lower P/E
54.97x vs 70.88x
P/B Ratio
VIJAYA has a lower P/B
13.65x vs 14.32x
EPS
VIJAYA has higher earnings per share
₹5.77 vs ₹1
Dividend Yield
THYROCARE has a higher dividend yield
1.41% vs 0.14%
Revenue Growth (TTM YoY)
VIJAYA has faster revenue growth
26.6% vs 19.7%
EPS Growth (TTM YoY)
THYROCARE has faster EPS growth
116.3% vs 38%
Qtr Sales Growth
THYROCARE has stronger quarterly sales growth
12.83% vs 10.57%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricTHYROCAREVIJAYA
SectorHealthcareHealthcare
IndustryHealthcare Service ProviderHealthcare Service Provider

Price

MetricTHYROCAREVIJAYA
Live Price₹498.25₹1,410.1
Day Change2.1%-0.39%
Volume2.22 L55,287
52-Week High₹1,610₹1,593.6
52-Week Low₹342.55₹848
Distance from 52W High-69.05%-11.51%

Valuation

MetricTHYROCAREVIJAYA
Market Cap₹7,926 Cr₹14,449 Cr
P/E Ratio54.97x70.88x
P/B Ratio14.32x13.65x
EPS₹1₹5.77
Book Value₹36.82₹92.93
Dividend Yield1.41%0.14%

Growth

MetricTHYROCAREVIJAYA
Revenue Growth (TTM YoY)19.7%26.6%
EPS Growth (TTM YoY)116.3%38%
Qtr Sales Growth12.83%10.57%
Qtr Profit Growth-70.35%12%

Profitability & Leverage

MetricTHYROCAREVIJAYA
ROE26.54%18.86%
ROCE28.32%22.72%
Net Margin19.67%20.91%
Operating Margin27.46%34.93%
Debt to Equity0x0x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricTHYROCAREVIJAYA
Promoter Holding51.02%▼ 9.9 pp52.46%▼ 0.01 pp
FII Holding9.37%▲ 3.93 pp10.66%▼ 0.99 pp
DII Holding25.92%▲ 5 pp32.5%▲ 0.92 pp
Public Holding13.7%▲ 0.98 pp4.38%▲ 0.07 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: THYROCARE TECH and VIJAYA DIAGNOSTIC CEN.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.